ERIC BJERKHOLT
CIK 1197350 · CHIEF FINANCIAL OFFICER · last filed 2026-07-08
ERIC BJERKHOLT is a CHIEF FINANCIAL OFFICER who has filed 124 SEC Form 4 insider transactions across 13 companies since 2007. The most recent filing shows the insider sold $611.3K of MIRM on Jul 8, 2026. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.54M
13
124
-$2.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIRM | CHIEF FINANCIAL OFFICER | 42,481 | $112.23 | $4.77M | -$2.31M | 17 | 2026-07-08 |
| MGX | Director | — | $1.21 | — | $0 | 3 | 2026-06-11 |
| CERS | Director | 261,679 | $2.92 | $764.1K | $37.5K | 17 | 2026-06-11 |
| SRZNW | Director | — | $0.02 | — | $0 | 4 | 2026-05-14 |
| CalciMedica, Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 1 | 2024-08-28 |
| CALC | Director | 3,534 | $0.72 | $2.5K | $6.7K | 7 | 2024-04-22 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Chief Financial Officer | 0 | $40.39 | $0 | -$231.7K | 9 | 2023-08-11 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| COLL | Chief Financial Officer | 0 | $35.90 | $0 | $316.9K | 15 | 2020-10-14 |
| Corium International, Inc. (CORI) Delisted | Director | 0 | — | — | $89.2K | 6 | 2018-11-28 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | EVP, CFO & Corp. Secretary | 10,683 | $18.62 | $198.9K | $20.2K | 23 | 2016-12-06 |
| STEM | Director | 1,521 | $5.33 | $8.1K | $0 | 12 | 2016-01-05 |
| Viracta Therapeutics, Inc. (SNSSD) Delisted | Sr. VP, CFO & Corp. Secretary | 84,582 | — | — | $0 | 1 | 2011-03-02 |
Recent Filings
124 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-08 | MIRM | Sell (S) | −5,000 | -$611.3K | EDGAR |
| 2026-07-06 | MIRM | Notice (144) | −5,000 | -$611.3K | EDGAR |
| 2026-06-11 | CERS | Sell (S) | −20,454 | -$53.2K | EDGAR |
| 2026-06-11 | MGX | Grant (A) | — | $0 | EDGAR |
| 2026-06-09 | CERS | Notice (144) | −20,454 | -$53.2K | EDGAR |
| 2026-06-09 | MIRM | Mixed | −2,607 | -$405.7K | EDGAR |
| 2026-06-08 | MIRM | Notice (144) | −5,000 | -$469.1K | EDGAR |
| 2026-06-02 | CERS | Grant (A) | +60,000 | $0 | EDGAR |
| 2026-05-14 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2026-03-17 | MIRM | Mixed | +6,047 | -$670.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.